A retrospective study assessing immune checkpoint inhibition (ICI)responses in patients with uveal melanoma
Latest Information Update: 15 Jun 2019
At a glance
- Drugs Tebentafusp (Primary)
- Indications Uveal melanoma
- Focus Therapeutic Use
Most Recent Events
- 15 Jun 2019 New trial record
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology